Brought to you by 
Reliant raises $150mm
22 Mar 2002
Executive Summary
Reliant Pharmaceuticals (marketing specialist set up in 1999 to boost sales and life spans of in-licensed drugs) raised $150mm in a Series B private placement led by drug delivery company Alkermes, and including returning investors Bay City Capital, the Prizker family, Versant Ventures, Invemed, and Morgan Stanley Dean Witter.
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Reliant raises $150mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice